scholarly article | Q13442814 |
P2093 | author name string | Sarah L Gaffen | |
Anna R Huppler | |||
Partha S Biswas | |||
Sudesh Pawaria | |||
Kritika Ramani | |||
Kelly Maers | |||
P2860 | cites work | Structure and signalling in the IL-17 receptor family | Q24648045 |
Act1, a negative regulator in CD40- and BAFF-mediated B cell survival | Q28593738 | ||
Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice | Q30308288 | ||
Innate IL-17-producing cells: the sentinels of the immune system | Q33608575 | ||
Immunopathogenesis of crescentic glomerulonephritis. | Q33716979 | ||
Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis | Q33979319 | ||
Immunopathogenesis of lupus and lupus nephritis: recent insights | Q34617832 | ||
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice | Q34729932 | ||
Recent advances in the IL-17 cytokine family | Q35301277 | ||
The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system | Q35541970 | ||
Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome | Q35576410 | ||
The role of interstitial cells in the progression of renal diseases | Q36185342 | ||
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis | Q36676453 | ||
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis | Q36886558 | ||
Th17 cells: from precursors to players in inflammation and infection | Q37173921 | ||
The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis | Q37181960 | ||
IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen | Q37181998 | ||
An overview of IL-17 function and signaling | Q37243055 | ||
A protective function for interleukin 17A in T cell-mediated intestinal inflammation | Q37260173 | ||
The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
Interleukin-17 and systemic lupus erythematosus: current concepts | Q37552021 | ||
The role of T helper subsets in autoimmunity and allergy | Q37580545 | ||
The Th17 immune response in renal inflammation | Q37726972 | ||
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease | Q37735334 | ||
The emergence of TH17 cells as effectors of renal injury. | Q37834852 | ||
Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases | Q37982180 | ||
Lupus nephritis. How latest insights into its pathogenesis promote novel therapies. | Q38027371 | ||
Targeting IL-17 and TH17 cells in chronic inflammation | Q38047820 | ||
Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody | Q38102538 | ||
IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement | Q39684742 | ||
Mediators of immune glomerular injury | Q40718992 | ||
Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice. | Q41875589 | ||
IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. | Q53576513 | ||
The antigen presentation function of renal tubular epithelial cells | Q72178352 | ||
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus | Q79305119 | ||
P433 | issue | 3 | |
P921 | main subject | glomerulonephritis | Q605006 |
autoimmune glomerulonephritis | Q55009191 | ||
P304 | page(s) | 463-472 | |
P577 | publication date | 2014-06-16 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis | |
P478 | volume | 96 |
Q40449540 | Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney. |
Q92860794 | Extracellular DNA traps in inflammation, injury and healing |
Q28080640 | GM-CSF: An immune modulatory cytokine that can suppress autoimmunity |
Q58567854 | IL-17 Receptor Signaling Negatively Regulates the Development of Tubulointerstitial Fibrosis in the Kidney |
Q93222504 | IL-17 in Renal Immunity and Autoimmunity |
Q87887570 | IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation |
Q49165257 | IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases |
Q40167802 | Interleukin-17-induced expression of monocyte chemoattractant protein-1 in cardiac myocytes requires nuclear factor κB through the phosphorylation of p65. |
Q37681533 | Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12 |
Q58721050 | Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases |
Q39376963 | Re-Examining Neutrophil Participation in GN. |
Q46325099 | T helper type 17 cells in immune-mediated glomerular disease |
Q41269620 | Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis |
Q93158317 | The IL-17 Family of Cytokines in Health and Disease |
Q28553220 | The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney |
Q52714508 | Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection. |
Search more.